Kwaśnik, P.; Kiełbus, M.; Zaleska, J.; Link-Lenczowska, D.; Zawada, M.; Wysogląd, H.; Sacha, T.; Giannopoulos, K.
The PD1 Molecule May Contribute to Lower Treatment-Free Remission Rates in Patients with Chronic Myeloid Leukemia with the e13a2 Transcript. J. Clin. Med. 2025, 14, 2304.
https://doi.org/10.3390/jcm14072304
AMA Style
Kwaśnik P, Kiełbus M, Zaleska J, Link-Lenczowska D, Zawada M, Wysogląd H, Sacha T, Giannopoulos K.
The PD1 Molecule May Contribute to Lower Treatment-Free Remission Rates in Patients with Chronic Myeloid Leukemia with the e13a2 Transcript. Journal of Clinical Medicine. 2025; 14(7):2304.
https://doi.org/10.3390/jcm14072304
Chicago/Turabian Style
Kwaśnik, Paulina, Michał Kiełbus, Joanna Zaleska, Dorota Link-Lenczowska, Magdalena Zawada, Hubert Wysogląd, Tomasz Sacha, and Krzysztof Giannopoulos.
2025. "The PD1 Molecule May Contribute to Lower Treatment-Free Remission Rates in Patients with Chronic Myeloid Leukemia with the e13a2 Transcript" Journal of Clinical Medicine 14, no. 7: 2304.
https://doi.org/10.3390/jcm14072304
APA Style
Kwaśnik, P., Kiełbus, M., Zaleska, J., Link-Lenczowska, D., Zawada, M., Wysogląd, H., Sacha, T., & Giannopoulos, K.
(2025). The PD1 Molecule May Contribute to Lower Treatment-Free Remission Rates in Patients with Chronic Myeloid Leukemia with the e13a2 Transcript. Journal of Clinical Medicine, 14(7), 2304.
https://doi.org/10.3390/jcm14072304